|
|
 |
|
Viewing report
|
|
|
|
The Pharmaceutical Market: Lithuania
Espicom Business Intelligence Ltd, Oct 2011, Pages: 52
THE PHARMACEUTICAL MARKET: LITHUANIA - REVIEW
The Lithuanian economy decreased considerably in 2009 but the economy is now recovering and a small level of growth is expected in 2011, as private consumption and investment spending increases. Health expenditure growth will remain steady, increasing by a moderate CAGR between 2011 and 2016. The country currently spends a proportion of GDP on healthcare similar to Bulgaria and Hungary. Nearly three-quarters of expenditure is in the public sector, and since 1997, this has been almost entirely through the Compulsory Health Insurance Fund. Politically, the Lithuanian government has lost its majority in parliament as a number of members have moved to the opposition. The economy minister resigned in March 2011 and a further loss of ministers could lead to the formation of a new coalition.
The health of Lithuanians continues to be generally poor, as elsewhere in the former USSR. Poor diet, high levels of smoking and alcoholism and low awareness of health issues have led to high levels of morbidity and a relatively low life expectancy, especially for men. According to the Lithuanian Health Information Centre, alcohol abuse remains a significant problem, although the number of deaths from alcohol-related causes is starting to decrease. The government estimates that there are over 500,000 actual or potential alcoholics, resulting in a high incidence of alcohol-related illness, deaths from alcohol poisoning, and suicides. Circulatory diseases and cancer are the leading causes of death.
Lithuania has a small yet expanding pharmaceutical market, with a strong generic sector. In 2011, the Lithuanian pharmaceutical market is comparable in size to Serbia and similar to Poland in per capita terms. The market is expected to expand at a moderate CAGR over the next few years; in per capita terms, spending will be above the regional average in 2016. The country was hit particularly hard by the global economic crisis, but growth in the Lithuanian pharmaceutical market will pick up as the economy continues to recover and imports strengthen. A large proportion of the market is supplied by imports, principally from other European countries. Generics represent around two thirds of the market in terms of volume. Sales of generics could increase in the future if the government goes ahead with plans to make generic drugs at least 30% cheaper than their branded equivalents.
ENHANCED STRATEGIC INTELLIGENCE
These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:
- Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
- Specialised intelligence on OTCs, generics, biologics and biosimilars.
- Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
- A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
- The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.
HEALTHCARE STATISTICS
A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.
Customers who bought this item also bought
The Pharmaceutical Market: Ukraine
The Pharmaceutical Market: Germany
The Pharmaceutical Market: Latvia
The Pharmaceutical Market: Pakistan
The Pharmaceutical Market: Slovakia
The Pharmaceutical Market: Croatia
The Pharmaceutical Market: Bulgaria
The Pharmaceutical Market: Serbia
The Pharmaceutical Market: Israel
The Pharmaceutical Market: Estonia
|
|
|
|
